Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

During the Trading Day
263.86 -9.41 / -3.44%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
263.81 -0.0528 / -0.02%
 
Volume: 55.2K

Today’s Trading

Previous close273.27
Today’s open271.10
Day’s range258.46 - 272.67
Volume2,856,944
Average volume (3 months)2,413,677
Market cap$59.8B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+19.91%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+39.61%
P/E ratio17.2
Price/Sales8.30
Price/Book5.93

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc-0.91-2.34%
BAXBaxter International...-0.80-2.09%
AMGNAmgen-4.87-3.25%
XONIntrexon Corp+1.01+2.89%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$4.41
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Senior Medical Director
Diego Cadavid
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers